The company, which develops antimicrobial implants and medical devices to address surgical site and hospital-acquired infections, now has three patents that cover substrates such as surgical meshes and sutures, and also orthopedic devices like screws and large-joint implants.
The company’s first product is a cannulated bone screw that aims to reduce microbial contamination for orthopedic reduction and internal fixation procedures. It is awaiting regulatory approval.
More articles on devices:
17 spine devices receive FDA 510(k) clearance in December
Amedica restructuring includes 28% staff reduction, new spine focus—5 key points
Bacterin revenue up for 5th consecutive quarter—5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
